Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
The article presents current data on the effect of drugs for the treatment of gout on the composition and function of the intestinal microbiota. The potential possibilities of pre- and probiotics use for the prevention and complex therapy of gout are discussed, therapeutic effect may be associated w...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2022-12-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1366 |
_version_ | 1797876652820135936 |
---|---|
author | M. S. Eliseev E. N. Kharlamova O. V. Zhelyabina A. M. Lila |
author_facet | M. S. Eliseev E. N. Kharlamova O. V. Zhelyabina A. M. Lila |
author_sort | M. S. Eliseev |
collection | DOAJ |
description | The article presents current data on the effect of drugs for the treatment of gout on the composition and function of the intestinal microbiota. The potential possibilities of pre- and probiotics use for the prevention and complex therapy of gout are discussed, therapeutic effect may be associated with their impact on the uric acid synthesis and intestinal excretion, as well as with anti-inflammatory properties. The need for further research in this area is emphasized. |
first_indexed | 2024-04-10T02:05:06Z |
format | Article |
id | doaj.art-2e32cb6a1e1a46e58d8c50f3b0c8d7b0 |
institution | Directory Open Access Journal |
issn | 1996-7012 2310-158X |
language | Russian |
last_indexed | 2024-04-10T02:05:06Z |
publishDate | 2022-12-01 |
publisher | IMA-PRESS LLC |
record_format | Article |
series | Современная ревматология |
spelling | doaj.art-2e32cb6a1e1a46e58d8c50f3b0c8d7b02023-03-13T08:39:30ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2022-12-0116671110.14412/1996-7012-2022-6-7-112531Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiotaM. S. Eliseev0E. N. Kharlamova1O. V. Zhelyabina2A. M. Lila3Научно-исследовательский институт ревматологии им. В.А. НасоновойНаучно-исследовательский институт ревматологии им. В.А. НасоновойНаучно-исследовательский институт ревматологии им. В.А. НасоновойНаучно-исследовательский институт ревматологии им. В.А. Насоновой; Российская медицинская академия непрерывного профессионального образования Минздрава РоссииThe article presents current data on the effect of drugs for the treatment of gout on the composition and function of the intestinal microbiota. The potential possibilities of pre- and probiotics use for the prevention and complex therapy of gout are discussed, therapeutic effect may be associated with their impact on the uric acid synthesis and intestinal excretion, as well as with anti-inflammatory properties. The need for further research in this area is emphasized.https://mrj.ima-press.net/mrj/article/view/1366микробиотаподаграгиперурикемияпробиотикипребиотикифебуксостаталлопуринол |
spellingShingle | M. S. Eliseev E. N. Kharlamova O. V. Zhelyabina A. M. Lila Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota Современная ревматология микробиота подагра гиперурикемия пробиотики пребиотики фебуксостат аллопуринол |
title | Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota |
title_full | Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota |
title_fullStr | Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota |
title_full_unstemmed | Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota |
title_short | Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota |
title_sort | microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout part 2 gout therapy and the gut microbiota |
topic | микробиота подагра гиперурикемия пробиотики пребиотики фебуксостат аллопуринол |
url | https://mrj.ima-press.net/mrj/article/view/1366 |
work_keys_str_mv | AT mseliseev microbiotaasanewpathogeneticfactorinthedevelopmentofchronichyperuricemiaandgoutpart2gouttherapyandthegutmicrobiota AT enkharlamova microbiotaasanewpathogeneticfactorinthedevelopmentofchronichyperuricemiaandgoutpart2gouttherapyandthegutmicrobiota AT ovzhelyabina microbiotaasanewpathogeneticfactorinthedevelopmentofchronichyperuricemiaandgoutpart2gouttherapyandthegutmicrobiota AT amlila microbiotaasanewpathogeneticfactorinthedevelopmentofchronichyperuricemiaandgoutpart2gouttherapyandthegutmicrobiota |